A recent market study indicates that the Europe Platelet Rich Plasma (PRP) market, valued at over US$ 57.5 million in 2023, is on a trajectory for significant growth, with expectations to ascend to a market valuation of US$ 80.3 million by 2033. This growth trend reflects a stable Compound Annual Growth Rate (CAGR) of 3.4% …